Exponent, Inc. $EXPO Shares Sold by ProShare Advisors LLC

ProShare Advisors LLC lessened its stake in Exponent, Inc. (NASDAQ:EXPO) by 93.7% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 7,998 shares of the business services provider’s stock after selling 118,107 shares during the quarter. ProShare Advisors LLC’s holdings in Exponent were worth $523,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. Vise Technologies Inc. bought a new stake in shares of Exponent in the 3rd quarter valued at approximately $343,000. VIRGINIA RETIREMENT SYSTEMS ET Al bought a new stake in Exponent in the third quarter worth approximately $216,000. Signaturefd LLC increased its stake in shares of Exponent by 77.5% during the 3rd quarter. Signaturefd LLC now owns 1,624 shares of the business services provider’s stock worth $106,000 after purchasing an additional 709 shares during the last quarter. Citizens Financial Group Inc. RI bought a new position in shares of Exponent during the 3rd quarter valued at $379,000. Finally, Gibbs Wealth Management raised its holdings in shares of Exponent by 3.1% during the 3rd quarter. Gibbs Wealth Management now owns 4,759 shares of the business services provider’s stock valued at $311,000 after purchasing an additional 142 shares in the last quarter. Institutional investors and hedge funds own 92.37% of the company’s stock.

Insiders Place Their Bets

In related news, CEO Catherine Corrigan sold 1,707 shares of the stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $66.28, for a total value of $113,139.96. Following the completion of the transaction, the chief executive officer owned 129,108 shares of the company’s stock, valued at $8,557,278.24. This represents a 1.30% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, VP Richard Reiss sold 1,280 shares of the firm’s stock in a transaction dated Tuesday, November 3rd. The stock was sold at an average price of $86.44, for a total transaction of $110,643.20. Following the transaction, the vice president owned 1,008 shares of the company’s stock, valued at approximately $87,131.52. This represents a 55.94% decrease in their position. The disclosure for this sale is available in the SEC filing. 1.70% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on EXPO shares. JPMorgan Chase & Co. boosted their price target on Exponent from $90.00 to $100.00 and gave the stock an “overweight” rating in a research report on Friday, October 30th. Weiss Ratings upgraded Exponent from a “hold (c-)” rating to a “hold (c)” rating in a report on Friday, October 9th. Zacks Research raised shares of Exponent from a “hold” rating to a “strong-buy” rating in a research report on Monday, November 2nd. Finally, UBS Group boosted their price objective on shares of Exponent from $72.00 to $82.00 and gave the stock a “neutral” rating in a research note on Friday, October 30th. One analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat, Exponent has a consensus rating of “Moderate Buy” and a consensus target price of $91.00.

Exponent Price Performance

NASDAQ:EXPO opened at $85.46 on Tuesday. The stock has a market cap of $4.06 billion, a P/E ratio of 36.84 and a beta of 0.66. Exponent, Inc. has a one year low of $51.91 and a one year high of $90.51. The company has a fifty day moving average price of $72.01 and a 200 day moving average price of $67.00.

Exponent (NASDAQ:EXPO) last posted its quarterly earnings results on Thursday, October 29th. The business services provider reported $0.64 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.60 by $0.04. Exponent had a net margin of 17.40% and a return on equity of 34.61%. The company had revenue of $173.73 million for the quarter, compared to analyst estimates of $149.64 million. During the same period last year, the business posted $0.55 EPS. The business’s quarterly revenue was up 11.7% on a year-over-year basis. As a group, equities research analysts anticipate that Exponent, Inc. will post 2.36 EPS for the current year.

Exponent Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, December 18th. Investors of record on Friday, December 4th will be given a $0.31 dividend. This represents a $1.24 annualized dividend and a yield of 1.5%. The ex-dividend date of this dividend is Friday, December 4th. Exponent’s dividend payout ratio (DPR) is 53.45%.

Exponent Profile

Exponent, Inc is a multidisciplinary engineering and scientific consulting firm that helps clients investigate complex technical issues and manage risk. Its consultants analyze incidents such as product failures and accidents, assess potential hazards, and provide expert advice on engineering, scientific, and regulatory matters.

The company’s services span fields including engineering, materials science, environmental science, health, and data analytics. Clients use Exponent’s expertise for product development and testing, litigation support, regulatory compliance, and risk assessment across a range of industries.

Founded in 1967 as Failure Analysis Associates, the company adopted the Exponent name in 1998.